Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in AKBA — Akebia Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$270,083
+$133,178 QoQ
Shares Held
236,916
+140.5% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 170 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. AKBA ranks #37 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in AKBA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $270,083 236,916
2026-03-31 $136,905 98,493
2025-12-31 $460,080 285,765
2025-09-30 $518,942 190,089
2025-06-30 $580,911 159,591
2025-03-31 $249,833 130,122
2024-12-31 $232,553 122,397
2024-09-30 $131,072 99,298
2024-06-30 $98,020 96,099
2024-03-31 $14,716 8,042
2023-12-31 $13,757 11,096
2023-09-30 $12,553 11,013
2023-06-30 $10,184 11,131
2023-03-31 $6,866 12,264
2022-12-31 $7,775 13,479
2022-09-30 $4,364 13,814
2022-06-30 $5,278 14,956
2022-03-31 $212,263 295,633
2021-12-31 $786,372 347,953
2021-09-30 $419,930 145,810
2021-06-30 $74,475 19,651
2021-03-31 $366,915 108,395
2020-12-31 $729,975 260,706
2020-09-30 $782,842 311,890
2020-06-30 $4,159,865 306,323
2020-03-31 $1,837,034 242,353